ELV Stock Overview
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 4/6 |
Elevance Health, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$494.90 |
52 Week High | US$504.20 |
52 Week Low | US$374.00 |
Beta | 0.81 |
1 Month Change | 7.52% |
3 Month Change | 7.59% |
1 Year Change | 19.54% |
3 Year Change | 53.31% |
5 Year Change | n/a |
Change since IPO | 101.69% |
Recent News & Updates
Recent updates
Shareholder Returns
ELV | AT Healthcare | AT Market | |
---|---|---|---|
7D | -1.8% | 2.3% | -0.1% |
1Y | 19.5% | -4.8% | 5.7% |
Return vs Industry: ELV exceeded the Austrian Healthcare industry which returned -4.8% over the past year.
Return vs Market: ELV exceeded the Austrian Market which returned 5.7% over the past year.
Price Volatility
ELV volatility | |
---|---|
ELV Average Weekly Movement | 2.4% |
Healthcare Industry Average Movement | 5.1% |
Market Average Movement | 3.4% |
10% most volatile stocks in AT Market | 5.0% |
10% least volatile stocks in AT Market | 1.7% |
Stable Share Price: ELV has not had significant price volatility in the past 3 months.
Volatility Over Time: ELV's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 104,900 | Gail Boudreaux | www.elevancehealth.com |
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Elevance Health, Inc. Fundamentals Summary
ELV fundamental statistics | |
---|---|
Market cap | €113.98b |
Earnings (TTM) | €5.83b |
Revenue (TTM) | €160.48b |
19.5x
P/E Ratio0.7x
P/S RatioIs ELV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ELV income statement (TTM) | |
---|---|
Revenue | US$171.75b |
Cost of Revenue | US$124.09b |
Gross Profit | US$47.66b |
Other Expenses | US$41.41b |
Earnings | US$6.24b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 26.87 |
Gross Margin | 27.75% |
Net Profit Margin | 3.64% |
Debt/Equity Ratio | 65.0% |
How did ELV perform over the long term?
See historical performance and comparisonDividends
1.2%
Current Dividend Yield23%
Payout RatioDoes ELV pay a reliable dividends?
See ELV dividend history and benchmarksElevance Health dividend dates | |
---|---|
Ex Dividend Date | Jun 10 2024 |
Dividend Pay Date | Jun 25 2024 |
Days until Ex dividend | 38 days |
Days until Dividend pay date | 53 days |
Does ELV pay a reliable dividends?
See ELV dividend history and benchmarks